BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND ATM, TELO1, 472, ENSG00000149311, TEL1, ATD, ATE, DKFZp781A0353, AT1, Q13315, MGC74674, ATDC, ATC, ATA AND Staging
13 results:

  • 1. Serum glypican-3 for the prediction of survival in patients with hepatocellular carcinoma.
    Nicolosi A; Gaia S; Risso A; Rosso C; Rolle E; Abate ML; Olivero A; Armandi A; Ribaldone DG; Carucci P; Fagoonee S; Pellicano R; Saracco GM; Bugianesi E; Caviglia GP
    Minerva Gastroenterol (Torino); 2022 Dec; 68(4):378-386. PubMed ID: 36222678
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Fusion imaging in preoperative assessment of extent of disease in patients with advanced ovarian cancer: feasibility and agreement with laparoscopic findings.
    Moro F; Bertoldo V; Avesani G; Moruzzi MC; Mascilini F; Bolomini G; Caliolo G; Esposito R; Moroni R; Zannoni GF; Fagotti A; Manfredi R; Scambia G; Testa AC
    Ultrasound Obstet Gynecol; 2021 Dec; 58(6):916-925. PubMed ID: 33847427
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Validation of the 8th AJCC cancer staging System for Pancreas Neuroendocrine Tumors Using Korean Nationwide Surgery Database.
    You Y; Jang JY; Kim SC; Yoon YS; Park JS; Cho CK; Park SJ; Yang JD; Lee WJ; Hong TH; Ahn KS; Jeong CY; Lee HK; Lee SE; Roh YH; Kim HJ; Kim H; Han IW
    Cancer Res Treat; 2019 Oct; 51(4):1639-1652. PubMed ID: 30999719
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Long term results of down-staging and liver transplantation for patients with hepatocellular carcinoma beyond the conventional criteria.
    Ravaioli M; Odaldi F; Cucchetti A; Trevisani F; Piscaglia F; De Pace V; Bertuzzo VR; Neri F; Golfieri R; Cappelli A; D'Errico A; Cescon M; Del Gaudio M; Fallani G; Siniscalchi A; Morelli MC; Ciccarese F; Di Marco M; Farinati F; Giannini EG; Pinna AD
    Sci Rep; 2019 Mar; 9(1):3781. PubMed ID: 30846792
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Radiomics score: a potential prognostic imaging feature for postoperative survival of solitary HCC patients.
    Zheng BH; Liu LZ; Zhang ZZ; Shi JY; Dong LQ; Tian LY; Ding ZB; Ji Y; Rao SX; Zhou J; Fan J; Wang XY; Gao Q
    BMC Cancer; 2018 Nov; 18(1):1148. PubMed ID: 30463529
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. External validation of the ITA.LI.CA prognostic system for patients with hepatocellular carcinoma: A multicenter cohort study.
    Borzio M; Dionigi E; Rossini A; Marignani M; Sacco R; De Sio I; Bertolini E; Francica G; Giacomin A; Parisi G; Vicari S; Toldi A; Salmi A; Boccia S; Mitra M; Fornari F
    Hepatology; 2018 Jun; 67(6):2215-2225. PubMed ID: 29165831
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Prognostic nomograms for patients with resectable hepatocelluar carcinoma incorporating systemic inflammation and tumor characteristics.
    Shen J; He L; Li C; Wen T; Chen W; Lu C; Yan L; Li B; Yang J
    Oncotarget; 2016 Dec; 7(49):80783-80793. PubMed ID: 27811374
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Mesenteric Tumor Deposits in Midgut Small Intestinal Neuroendocrine Tumors Are a Stronger Indicator Than Lymph Node Metastasis for liver Metastasis and Poor Prognosis.
    Fata CR; Gonzalez RS; Liu E; Cates JM; Shi C
    Am J Surg Pathol; 2017 Jan; 41(1):128-133. PubMed ID: 27684993
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Metallothionein - immunohistochemical cancer biomarker: a meta-analysis.
    Gumulec J; Raudenska M; Adam V; Kizek R; Masarik M
    PLoS One; 2014; 9(1):e85346. PubMed ID: 24416395
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The impact of CT follow-up interval on stages of hepatocellular carcinomas detected during the surveillance of patients with liver cirrhosis.
    Chung YE; Kim MJ; Park MS; Choi JY; Lim JS; Kim KA; Kim KW
    AJR Am J Roentgenol; 2012 Oct; 199(4):816-21. PubMed ID: 22997373
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Hepatic resection combined with radiofrequency ablation for initially unresectable colorectal liver metastases after effective chemotherapy is a safe procedure with a low incidence of local recurrence.
    Mima K; Beppu T; Chikamoto A; Miyamoto Y; Nakagawa S; Kuroki H; Okabe H; Hayashi H; Sakamoto Y; Watanabe M; Kikuchi K; Baba H
    Int J Clin Oncol; 2013 Oct; 18(5):847-55. PubMed ID: 22940848
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Use of antiviral therapy in surveillance: impact on outcome of hepatitis B-related hepatocellular carcinoma.
    Chan SL; Mo FK; Wong VW; Liem GS; Wong GL; Chan VT; Poon DM; Loong HH; Yeo W; Chan AT; Mok TS; Chan HL
    Liver Int; 2012 Feb; 32(2):271-8. PubMed ID: 22098536
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Hepatectomy for hepatocellular carcinoma: the surgeon's role in long-term survival.
    Fan ST; Ng IO; Poon RT; Lo CM; Liu CL; Wong J
    Arch Surg; 1999 Oct; 134(10):1124-30. PubMed ID: 10522859
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.